Review



recombinant cd98 extra cellular domain protein  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Novus Biologicals recombinant cd98 extra cellular domain protein
    Recombinant Cd98 Extra Cellular Domain Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+cd98+extra+cellular+domain+protein/Recombinant+Human+CD98+His+Protein/10__3390_slash_cancers18071086-207-7-28
    Average 94 stars, based on 1 article reviews
    recombinant cd98 extra cellular domain protein - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Neutralization:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Recombinant:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Isolation:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Concentration Assay:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Cell Culture:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Clinical Proteomics:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Imaging:

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [21] via cBioPortal [24], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..

    Article Title: Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma
    Article Snippet: From the CLCA cohort [ ] via cBioPortal [ ], diagnostic sensitivity (%) of blood AFP (cutoffs: 200 ng/mL and 20 ng/mL) and PIVKA-II (cutoff: 40 mAU/mL) for early (BCLC 0 & A, n = 28) versus late HCC (BCLC B, n = 81; BCLC C, n = 130) were displayed as bar graphs; Figure S2: Comparison of three anti-CD98 antibodies for detecting extracellular CD98 on cells and EVs. (A) Surface CD98 on HepG2 cells quantified using three antibodies (Abcam ab307587, Novus NBP2-36491SS, NHRI#20D5) by flow cytometry. .. NHRI#20D5 specificity was validated via neutralization with recombinant CD98 extra-cellular domain protein. (B) CD98+ EVs isolated from HepG2-conditioned medium were measured using anti-CD63/CD9 nanobeads and anti-CD98 antibodies (Abcam, Novus, NHRI#20D5) with ExoCounter analysis; Figure S3: Determination of EV concentration and size of HepG2 cell culture media and plasma. (A) EV concentration and size in HepG2 cell culture media by nanoparticle tracking analysis (NTA) in the left bar plot and super-resolution STED imaging of HepG2 extracellular vesicles in the right image. ..



    Similar Products

    recombinant cd98 extra cellular domain protein  (Novus Biologicals)
    94
    Novus Biologicals recombinant cd98 extra cellular domain protein
    Recombinant Cd98 Extra Cellular Domain Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+cd98+extra+cellular+domain+protein/Recombinant+Human+CD98+His+Protein/10__3390_slash_cancers18071086-207-7-28
    Average 94 stars, based on 1 article reviews
    recombinant cd98 extra cellular domain protein - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results